164 related articles for article (PubMed ID: 10961382)
1. Stereoselectivity at the beta2-adrenoceptor on macrophages is a major determinant of the anti-inflammatory effects of beta2-agonists.
Izeboud CA; Vermeulen RM; Zwart A; Voss HP; van Miert AS; Witkamp RF
Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):184-9. PubMed ID: 10961382
[TBL] [Abstract][Full Text] [Related]
2. Modulation of interleukin-6 by beta2-adrenoceptor in endotoxin-stimulated renal macrophage cells.
Nakamura A; Johns EJ; Imaizumi A; Yanagawa Y; Kohsaka T
Kidney Int; 1999 Sep; 56(3):839-49. PubMed ID: 10469353
[TBL] [Abstract][Full Text] [Related]
3. Agonist-induced β2-adrenoceptor desensitization and downregulation enhance pro-inflammatory cytokine release in human bronchial epithelial cells.
Oehme S; Mittag A; Schrödl W; Tarnok A; Nieber K; Abraham G
Pulm Pharmacol Ther; 2015 Feb; 30():110-20. PubMed ID: 24915152
[TBL] [Abstract][Full Text] [Related]
4. Cyclic Adenosine Monophosphate-Mediated Enhancement of Vascular Endothelial Growth Factor Released by Differentiated Human Monocytic Cells: The Role of Protein Kinase A.
El-Zohairy SN; Oriowo MA; Ezeamuzie CI
Med Princ Pract; 2015; 24(6):548-54. PubMed ID: 26139101
[TBL] [Abstract][Full Text] [Related]
5. Beta-adrenergic receptor agonists induce the release of granulocyte chemotactic protein-2, oncostatin M, and vascular endothelial growth factor from macrophages.
Verhoeckx KC; Doornbos RP; Witkamp RF; van der Greef J; Rodenburg RJ
Int Immunopharmacol; 2006 Jan; 6(1):1-7. PubMed ID: 16332507
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of beta2-adrenoceptor desensitization on the IgE-dependent release of chemical mediators from cultured human mast cells.
Tsuji T; Kato T; Kimata M; Miura T; Serizawa I; Inagaki N; Nagai H
Biol Pharm Bull; 2004 Oct; 27(10):1549-54. PubMed ID: 15467193
[TBL] [Abstract][Full Text] [Related]
7. Desensitization of beta2-adrenoceptor-mediated responses by short-acting beta2-adrenoceptor agonists in human lung mast cells.
Chong LK; Suvarna K; Chess-Williams R; Peachell PT
Br J Pharmacol; 2003 Feb; 138(3):512-20. PubMed ID: 12569076
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of the beta-adrenergic receptor agonist zilpaterol on the LPS-induced production of TNF-alpha in vitro and in vivo.
Verhoeckx KC; Doornbos RP; van der Greef J; Witkamp RF; Rodenburg RJ
J Vet Pharmacol Ther; 2005 Dec; 28(6):531-7. PubMed ID: 16343285
[TBL] [Abstract][Full Text] [Related]
9. β2-adrenoreceptor stimulation dampens the LPS-induced M1 polarization in pig macrophages.
Bacou E; Haurogné K; Allard M; Mignot G; Bach JM; Hervé J; Lieubeau B
Dev Comp Immunol; 2017 Nov; 76():169-176. PubMed ID: 28633932
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of basal and stimulated release of endothelin-1 from guinea pig tracheal epithelial cells in culture by beta 2-adrenoceptor agonists and cyclic AMP enhancers.
Yang Q; Battistini B; Pelletier S; Sirois P
Inflammation; 2007 Oct; 30(5):136-47. PubMed ID: 17620004
[TBL] [Abstract][Full Text] [Related]
11. Loss of surface beta-2 adrenoceptors accounts for the insensitivity of cultured human monocytes to beta-2 adrenoceptor agonists.
Ezeamuzie CI; Shihab PK; Al-Radwan R
Int Immunopharmacol; 2011 Sep; 11(9):1189-94. PubMed ID: 21481814
[TBL] [Abstract][Full Text] [Related]
12. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological evidence for beta2-adrenoceptor in right atria from stressed female rats.
Spadari-Bartfisch RC; Santos IN; Vanderlei LC; Marcondes FK
Can J Physiol Pharmacol; 1999 Jun; 77(6):432-40. PubMed ID: 10537229
[TBL] [Abstract][Full Text] [Related]
14. The effects of S1319, a novel marine sponge-derived beta2-adrenoceptor agonist, on IgE-mediated activation of human cultured mast cells.
Suzuki H; Ueno A; Takei M; Shindo K; Higa T; Fukamachi H
Inflamm Res; 2000 Feb; 49(2):86-94. PubMed ID: 10738947
[TBL] [Abstract][Full Text] [Related]
15. Stereochemistry of an agonist determines coupling preference of beta2-adrenoceptor to different G proteins in cardiomyocytes.
Woo AY; Wang TB; Zeng X; Zhu W; Abernethy DR; Wainer IW; Xiao RP
Mol Pharmacol; 2009 Jan; 75(1):158-65. PubMed ID: 18838481
[TBL] [Abstract][Full Text] [Related]
16. Beta-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells.
Wang XS; Lau HY
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):746-50. PubMed ID: 16895550
[TBL] [Abstract][Full Text] [Related]
17. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Baker JG
Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
[TBL] [Abstract][Full Text] [Related]
18. Antidepressants suppress neuropathic pain by a peripheral β2-adrenoceptor mediated anti-TNFα mechanism.
Bohren Y; Tessier LH; Megat S; Petitjean H; Hugel S; Daniel D; Kremer M; Fournel S; Hein L; Schlichter R; Freund-Mercier MJ; Yalcin I; Barrot M
Neurobiol Dis; 2013 Dec; 60():39-50. PubMed ID: 23978467
[TBL] [Abstract][Full Text] [Related]
19. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists.
Kitagawa Y; Adachi-Akahane S; Nagao T
Br J Pharmacol; 1995 Sep; 116(1):1635-43. PubMed ID: 8564230
[TBL] [Abstract][Full Text] [Related]
20. Influence of agonist intrinsic activity on the desensitisation of beta2-adrenoceptor-mediated responses in mast cells.
Scola AM; Chong LK; Chess-Williams R; Peachell PT
Br J Pharmacol; 2004 Sep; 143(1):71-80. PubMed ID: 15289287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
